Stephen Gordon, Chief Financial Officer at TransMedics Group, Inc. (TMDX), sold 15,000 shares at $74.01 ($1.1M) on 2024-04-01, disclosed to the SEC on 2024-04-02.
Scheduled sale ($1.1M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TMDX | SELL | 2024-05-08 | $1.9M | — | Filing → |
| TMDX | SELL | 2024-03-12 | $334K | — | Filing → |
| TMDX | SELL | 2024-03-05 | $1.2M | — | Filing → |